PeptideHelper.org
Your evidence-based peptide reference
Research reference only. Not medical advice. Most compounds are not FDA-approved. Consult a qualified clinician before any human use.

Cognitive Enhancement

Adamax

N-acetyl-Semax amidate variant

Classification: Modified Semax analog (nootropic)

Mechanism: Similar to Semax; BDNF/NGF upregulation; enhanced stability

Benefits: Enhanced cognition vs Semax; focus/memory/mood

Evidence tier: Anecdotal · Availability: Research Chemical

Primary sources

  1. Gusev EI et al. The efficacy of semax in the treatment of patients at different stages of ischemic stroke. Zh Nevrol Psikhiatr Im S S Korsakova 2018. PMID 29798983
  2. Agapova TY et al. Neurotrophin gene expression in rat brain under the action of Semax, an analogue of ACTH 4-10. Neurosci Lett 2007. PMID 17353092
  3. Note: Adamax is a Semax derivative (N-acetyl-amidate variant) without independent indexed primary literature; cited papers describe the parent Semax peptide.

Loading interactive view…